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Abstract
Context: Because positive biomedical observations are more often published than those reporting no effect, initial
observations are often refuted or attenuated by subsequent studies.
Objective: To determine whether newspapers preferentially report on initial findings and whether they also report on
subsequent studies.
Methods: We focused on attention deficit hyperactivity disorder (ADHD). Using Factiva and PubMed databases, we
identified 47 scientific publications on ADHD published in the 1990s and soon echoed by 347 newspapers articles. We
selected the ten most echoed publications and collected all their relevant subsequent studies until 2011. We checked
whether findings reported in each ‘‘top 10’’ publication were consistent with previous and subsequent observations. We
also compared the newspaper coverage of the ‘‘top 10’’ publications to that of their related scientific studies.
Results: Seven of the ‘‘top 10’’ publications were initial studies and the conclusions in six of them were either refuted or
strongly attenuated subsequently. The seventh was not confirmed or refuted, but its main conclusion appears unlikely.
Among the three ‘‘top 10’’ that were not initial studies, two were confirmed subsequently and the third was attenuated. The
newspaper coverage of the ‘‘top 10’’ publications (223 articles) was much larger than that of the 67 related studies (57
articles). Moreover, only one of the latter newspaper articles reported that the corresponding ‘‘top 10’’ finding had been
attenuated. The average impact factor of the scientific journals publishing studies echoed by newspapers (17.1 n = 56) was
higher (p,0.0001) than that corresponding to related publications that were not echoed (6.4 n = 56).
Conclusion: Because newspapers preferentially echo initial ADHD findings appearing in prominent journals, they report on
uncertain findings that are often refuted or attenuated by subsequent studies. If this media reporting bias generalizes to
health sciences, it represents a major cause of distortion in health science communication.
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quality media reporting of biomedical issues should consider a
body of scientific studies over time, rather than merely initial
publications [4]. This is all the more desirable since initial
biomedical findings are often contradicted or attenuated by
subsequent studies [6–8]. This devaluation trend is not surprising,
from a scientific point of view, given that positive results are more
often published than negative ones [6,9].
We hypothesize here that the devaluation trend of initial
findings is largely ignored by the media. Indeed, because of their
novelty, initial observations tend to be published in prestigious
scientific journals [6,8] and, although data are still lacking, it is
likely that most subsequent studies are published in less prestigious

Introduction
Because the mass media are a key source of health science
information for the lay public and for many professionals, the
accuracy of media reporting is a matter of concern. Numerous
studies have investigated how the media report on single
biomedical studies. Depending on medias and topics, the reporting
accuracy ranges from poor to more accurate than expected [1–3].
However, ‘‘assessing accuracy in the reporting of a single study
does not address whether the coverage contextualizes, where the
study fits within an emerging body of knowledge’’ [4]. Biomedical
findings slowly mature from initial uncertain observations to facts
validated by subsequent independent studies [5]. Therefore, high
PLOS ONE | www.plosone.org
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ones. If media preferentially report on findings published in
prestigious journals, they may fail to reflect the scientific progress
from initial observations to high-quality evidence based on sets of
consistent scientific studies.
We focused on attention deficit hyperactivity disorder (ADHD),
which is considered to be the most common neurodevelopmental
disorder diagnosed in children, with a prevalence around 10%
among children aged 4 to 17 years in the United States [10]. It is
characterized by behavioral symptoms, mainly attention deficit
and impulsivity with or without hyperactivity. The ADHD
diagnosis rests only on these symptoms because no biological
markers (e.g. genetic tests, brain imaging) have been validated
[11]. Short-term studies have demonstrated that psychostimulant
medications significantly reduce ADHD symptoms [11,12].
However, according to recent reports, psychostimulant treatment
of ADHD-diagnosed children does not decrease long-term risks of
later antisocial behavior, substance use disorders and significant
academic underachievement [13–15]. Debates about the diagnosis
and treatment of ADHD persist in Europe and the USA [16].
To test our hypothesis, we selected the 10 scientific publications
related to ADHD that were most frequently echoed by Englishlanguage newspapers during the 1990s. For each of these ‘‘top 10’’
studies we collected all subsequent scientific articles on the same
specific topic as well as previous ones published in that decade. For
every publication, we noted the impact factor of the journal that
published it, the ranking of the university where the research was
performed, and the number of newspaper articles that reported on
it. We checked whether findings in each ‘‘top 10’’ publication were
consistent with subsequent observations on the same specific topic
until 2011. We also compared the newspaper coverage of the ‘‘top
10’’ publications to that of their related scientific studies.

published in weekly journals. For scientific publications published
in monthly journals our procedure included a preliminary step.
First, the time range was extended to two months and we looked
for the earliest occurrence of a Factiva article published by any
press agency (e.g. Reuters News, Associated Press). The date of this
early article was, then, taken as the starting date of a 10-day time
range, within which we performed the same systematic search. We
included newspaper articles from the printed general press, but
excluded articles from press agencies or published by specialized
weekly magazines (e.g. Biotech Week, Pharma Business Week). We
counted the number of newspaper articles echoing on each of the
47 scientific publications and ranked each publication by this
number.

Previous and subsequent scientific articles
For each ‘‘top 10’’ publication, we systematically searched
PubMed to identify any previous related scientific publications
appearing between 1990 and 1999, and any subsequent publications appearing until December 2011. Publications were selected if
they provided experimental observations on the specific topic
investigated in the corresponding ‘‘top 10’’ publication. To verify
that we did not miss relevant publications we also selected metaanalyses covering the same topic using the PubMed limit ‘‘metaanalysis’’. The ten boolean searches and the meta-analyses they
yielded are given in Table S2. For each identified publication we
used the Factiva database to look for newspaper articles reporting
on it according to the procedure described above. Searches
concluding that a scientific publication was not echoed by
newspapers were checked independently by two authors.

Content analysis of ‘‘top 10’’ publications and of their
related newspaper articles

Methods

In each ‘‘top 10’’ publication we identified the major finding
emphasized by most corresponding newspaper articles. Then, we
checked whether it agreed with findings published in related
studies. Whenever possible, deciding whether ‘‘top 10’’ findings
were confirmed, attenuated or refuted was based on systematic
review articles and meta-analyses published since 2008 and listed
in Table S2. When recent meta-analyses were not found, either we
considered the most recent study published by the same group
when it refuted the initial claim (Table S2), or we checked the
literature cited by articles published since 2008 on the same topic
(see our detailed account as Text S1). Our judgment was
performed in two steps by two authors familiar with the ADHD
literature. First, one author wrote a preliminary evaluation of each
‘‘top 10’’ article on the basis of the corresponding related studies.
Second, another author carefully checked this evaluation. Then,
both authors resolved their few disagreements by discussion and
built a detailed account of their judgment (Text S1). A brief
account is given below.
For the nine ‘‘top 10’’ publications questioned or refuted by
subsequent studies, we found 36 newspaper articles reporting on
these subsequent studies, including meta-analyses. We checked
whether any newspaper article mentioned that the scientific
publication they echoed actually questioned or refuted the
corresponding previous ‘‘top 10’’ publication. Because this analysis
was partly subjective, it was independently performed by two
coders. However, we observed no disagreement between them.

Selection of ‘‘top 10’’ scientific publications
The design of our study is illustrated in Fig. 1. We used the Dow
Jones Factiva database to locate scientific publications on ADHD
reported in English-language newspapers. This systematic search
was performed in two steps. First, we conducted a Boolean search
of the Factiva database using the keywords (hyperactivity OR
ADHD OR attention deficit) AND (researcher* OR scientist*)
applied from January 1, 1990 to December 31, 1999 within the
restricted sources ‘‘Major News and Business Publications’’. This
produced 1180 articles. We sorted these by relevance using the
Factiva tool and read the 300 most relevant ones to identify the
scientific publications they echoed. These scientific publications
were unequivocally identified in PubMed when their reference or
author’s name was given by the corresponding newspaper. In a
few cases where such details were lacking, we identified the
corresponding scientific publication by other details (university
where the study was conducted, date of publication, numerical
data). This first step retrieved 56 scientific publications. Among
them one meta-analysis, two review articles, one opinion article
and five articles only mentioning ADHD incidentally (e.g. a study
focused on Tourette’s syndrome) were not considered further. The
remaining 47 publications reported on primary observations. They
are listed as Table S1 with their respective number of associated
newspaper articles.
In the second step we looked for all newspaper articles reporting
on these 47 scientific publications. The following keyword Boolean
search (hyperactivity OR ADHD OR attention deficit) was
applied to the Factiva database without restriction regarding the
source (‘‘All sources’’) within a 10-day time range starting one day
before the publication date of every scientific publication
PLOS ONE | www.plosone.org

Journal impact factor and university ranking
We characterized each scientific publication by the impact
factor of the journal that published it and by the ranking of the
university in which the study was performed. For publications with
2
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Figure 1. Design of the study. The databases used in each step are indicated in italic. Details are given in the methods.
doi:10.1371/journal.pone.0044275.g001

authors from different universities, the university indicated in the
address of the corresponding author was selected. The impact
factor was given by ISI Web of Knowledge using the Journal Citation
Reports. We selected the 2009 edition and the 5-year impact factor.
To quantify the ranking of each university we used the 2010
edition of the freely available Academic Ranking of World Universities
(‘‘Shanghai Ranking’’ http://www.arwu.org) where the best-ranked is
assigned a score of one. We selected the ranking in Clinical Medicine
and Pharmacy. Because rankings in the ranges of 51–75 and 76–100
were not specified, we assigned the arbitrary score of 63 and 88,
respectively. Any university not classified among the top 100 was
given the arbitrary score of 120. The National Institutes of Health
in Bethesda, Maryland, are not listed in the ‘‘Shanghai Ranking’’.
Because of their prominence, however, we assigned them a score
of one.

Scientific follow-up of ‘‘top 10’’ publications reporting on
neurobiological observations
All four publications providing neurobiological data in humans
were initial studies [17–20]. Indeed, according to the authors and
in agreement with our own searches, the specific questions under
investigation were not previously tackled. In 1990 Zametkin and
coworkers used positron-emission tomography (PET) to measure
cerebral glucose metabolism in 25 adults with ADHD and in 50
normal adults while they performed an auditory task [17]. They
reported that mean global cerebral glucose metabolism was 8.1%
lower in the ADHD adults than in the normal controls. However,
4 subsequent studies from the same group fully disconfirmed the
initial finding [27–30].
LaHoste and coworkers showed in 1996 that the ‘‘7R’’ allele of
the gene coding for the D4 dopamine receptor was present in 49%
of ADHD children and in only 21% of the healthy control
children [18]. Fifteen subsequent investigations of this case-control
association, however, did not confirm this large difference (Fig. 2
and Table 2) [31–45]. Indeed, meta-analyses have repeatedly
concluded that the 7R allele confers a statistically significant, but
small, risk: it is present in 23% of ADHD children and in 17% of
controls [46,47].
In 1998 Vaidya et al. pointed out a selective effect of
methylphenidate (MPH) in ADHD. Using functional magnetic
resonance imaging they reported that, during an inhibition task,
MPH increased striatal activation in 10 ADHD children but
reduced it in six control children [19]. However, the reducing
effect of MPH in healthy children has neither been confirmed nor
refuted subsequently, according to our systematic search corroborated by Vaidya (personal communication, July 2011). A detailed
analysis of the data (see Text S1) shows that they are less
conclusive than claimed by the authors in their main conclusion.
In 1999 Fishman’s group used PET to measure the density of
the dopamine transporter (DAT) in 6 ADHD adults and 30
healthy controls [20]. They reported that DAT density was
elevated by 70% in the striatum of ADHD adults. However, 11
subsequent studies [48–58] and a meta-analysis [59] support the
conclusion that the DAT density in the striatum and/or its

Results
Identification and characteristics of ‘‘top 10’’ articles
From our initial search we retained 47 scientific publications
reporting primary observations related to ADHD and echoed at
least once by newspapers during the nine days following their
publication date. On average each publication was echoed by 7.4
newspaper articles (range: 1 to 37), but this media coverage was
unevenly distributed. Each ‘‘top 10’’ publication, listed in Table 1,
received an average of 22.3 newspaper articles (range: 13 to 37)
whereas the 37 others were echoed by 3.4 newspaper articles each
on average (range: 1 to 10) (Table 1 and Table S1). Examples of
newspaper titles are given in Table 1 and are highly representative
of all newspaper titles dealing with each ‘‘top 10’’ publication (data
not shown). Among these ‘‘top 10’’ publications, four reported on
neurobiological [17–20] and four on behavioral observations in
humans, [21–24], one on neurobiological and behavioral observations in mice [25] and one on epidemiological data [26]. All but
two appeared in highly prestigious journals, with an average 2009
impact factor of 26.6 (range: 5.8 to 51.4) (Table 1).

PLOS ONE | www.plosone.org
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Table 1. ‘‘Top 10’’ scientific studies published between 1990 and 1999 and most frequently echoed by newspapers.

Year

1st author

Scientific Title. Typical newspaper title

Journal. Newspaper

Impact factor

Media coverage

1990

Zametkin

Cerebral glucose metabolism in adults with
hyperactivity of childhood onset. Hyperactivity
linked to brain dysfunction.

N Engl J Med. Houston
Chronicle

51.4

18

1993

Hauser

Attention deficit-hyperactivity disorder in people
with generalized resistance to thyroid hormone.
Hyperactivity linked to genetic defect.

N Engl J Med. San
Francisco Chronicle

51.4

26

1994

Wolraich

Effects of diets high in sucrose or aspartame on
the behavior and cognitive performance of children.
Sweeteners-hyperactivity link is discounted.

N Engl J Med. The
New York Times

51.4

24

1996

Lahoste

Dopamine D4 receptor gene polymorphism is
associated with attention deficit hyperactivity
disorder. Genetic flaw linked to hyperactivity.

Mol Psychiatry.
Chicago Sun-Times

13

19

1996

Safer

Increased methylphenidate usage for attention
deficit disorder in the 1990s. Study sees lower
increase in Ritalin use.

Pediatrics. The Dallas
Morning News

5.8

23

1998

Vaidya

Selective effects of methylphenidate in attention
deficit hyperactivity disorder: a fMRI study. Scan
can diagnose kids’ ADD.

PNAS. Times Union

10.3

29

1999

Biederman

Pharmacotherapy of attention-deficit/hyperactivity
disorder reduces risk for substance use disorder.
Ritalin users may be less likely to abuse drugs.

Pediatrics. Denver Post

5.8

18

1999

Dougherty

Dopamine transporter density in patients with
attention deficit hyperactivity disorder. Brain
scans seen as test in attention disorder.

Lancet. The Boston Globe

29.4

37

1999

Gainetdinov

Role of serotonin in the paradoxical calming
effect of psychostimulants on hyperactivity.
Better attention deficit drugs possible.

Science. The Washington
Post

31.1

12

1999

MTA group

A 14-month randomized clinical trial of treatment
strategies for ADHD. Medicine best help for ADD.

Arch Gen Psychiatry.
The Cincinnati Post

16.4

17

doi:10.1371/journal.pone.0044275.t001

In 1994 Wolraich et al. reported that diets high in sucrose or
aspartame did not affect the behavior and cognitive performance
of 25 pre-school children and 23 school-age children described by
their parents as sensitive to sugar [22]. According to a metaanalysis [71], these observations were consistent with previous
studies, including three independent reports published between
1990 and 1994 [72–74]. This question has not been further
investigated (Table 2 and Text S1).
According to the US Drug Enforcement Administration the
production of MPH in the US increased nearly six-fold from 1990
to 1995 [26]. Whether or not this huge increase accurately
reflected the expansion of MPH treatment was a matter of debate
in the 1990s. According to Safer et al. (1996) there occurred a 2.5fold increase in the prevalence of MPH treatment of youths with
ADHD from 1990 to 1995 [26]. This estimate was less alarming
than a previous one [75]. Moreover, Safer’s data have been
questioned by a subsequent study [76]. However, Safer and
colleagues used another approach to confirm their original
estimate [77] and three studies by two independent groups also
reported estimates consistent with Safer’s study [78–80] (Table 2).
In 1999 Biederman et al. published a study showing that
pharmacotherapy of ADHD reduces the risk for later development
of substance use disorder (SUD) [23]. In 2003 the same group
published a meta-analysis supporting the same conclusion
although with a smaller effect size [81]. This meta-analysis
included several studies that were not published in peer-reviewed
journals and three studies reporting either an enhanced SUD risk
[82], a protective effect [23] or no effect [83]. Subsequent studies
either reported a protective effect [84,85] or no effect [13,14,86].

subdivisions is not obviously altered in ADHD patients (Fig. 3 and
Table 2).
Gainetdinov et al. proposed for the first time that genetically
modified mice lacking DAT might represent a model of ADHD
because they exhibited increased locomotion that was decreased in
response to psychostimulants [25]. They reported that this
‘‘calming’’ effect was not related to dopamine and might involve
the serotonin (5-HT) transporter because the same effect was
observed with the antidepressant drug fluoxetine, a specific
inhibitor of 5-HT uptake. However, two previous studies [60,61]
and a subsequent one [62] reported that antidepressants that
specifically inhibit the 5-HT transporter do not improve ADHD
symptoms. Two recent meta-analyses about ADHD medication in
children [63] and adults [64] do no recommend drugs targeting 5HT neurotransmission.

Scientific follow-up of other ‘‘top 10’’ publications
Four ‘‘top 10’’ publications reported on behavioral observations
in humans and two articles corresponded to initial studies. In an
initial 1993 study conducted in adults and children, Hauser et al.
reported that ‘‘subjects with generalized resistance to thyroid
hormone (RTH, a genetic disease) have a markedly increased
frequency of ADHD as compared to their unaffected family
members’’ [21]. However, three subsequent studies failed to find
evidence of RTH in large samples of children and adolescents with
ADHD [65–67]. Moreover, the association between untreated
RTH and ADHD has been further questioned (Table 2 and Text
S1) [68–70].

PLOS ONE | www.plosone.org
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conclusion of one publication [26] has been questioned by one
previous and one subsequent publication and confirmed by four
others. Finally, one publication has been fully confirmed by a
meta-analysis and not questioned subsequently [22].

Media articles reporting on meta-analyses related to ‘‘top
10’’ publications
Relevant meta-analyses were found for six ‘‘top 10’’ publications, but only two were echoed by newspapers. The 1994 study by
Wolraich et al. showing that sugar does not significantly affect
child behavior has been confirmed by a meta-analysis published by
the same group. This subsequent meta-analysis was also echoed by
16 newspaper articles that repeated Wolraich’s conclusion
(Table 2). The 1999 study by Biederman et al. was included in a
meta-analysis published in 2003 by the same investigators [81].
This meta-analysis was echoed by 10 newspapers articles stating
that psychostimulant treatment does not lead to drug abuse.
Moreover, seven out of these 10 articles added that medication
exerts a protective effect: ‘‘ADHD medication resulted in an
almost two-fold reduction in the risk of future substance abuse’’
(The Sydney Morning Herald). None, however, mentioned that the size
of this protective effect (1.8) was smaller than that reported in the
corresponding ‘‘top 10’’ study (3.9) (Fig. 4).

Figure 2. Association between ADHD and the D4 dopaminergic
receptor gene in initial and subsequent studies. The strength of
the association (i.e. the odd ratio, the ratio of prevalence of the 7R allele
of this DRD4 gene in ADHD children versus control children) in each
study is given in the ordinate. In 1996 LaHoste and coworkers published
the first study associating ADHD with the DRD4 gene [18]. This initial
study reported an odd ratio of 3.01. Subsequent case-control studies
reported smaller odd ratio (data from table 1A in [47]). According to
two recent meta-analyses [46,47], ADHD is still considered to be
significantly associated with the DRD4 gene although this association
confers a much smaller risk than initially thought (odd ratio indicated by
a diamond). Filled circles indicate scientific studies echoed by
newspapers (number of media articles indicated in parentheses). Empty
circles and diamonds indicate that the publication has not been echoed
by newspapers.
doi:10.1371/journal.pone.0044275.g002

Media articles reporting on scientific publications related
to ‘‘top 10’’ publications
Few scientific publications related to ‘‘top 10’’ publications were
echoed by newspapers (Table 2). Indeed, the subsequent scientific
studies related to five ‘‘top 10’’ publications [17–19,21,25]
received no media coverage at all. Among the articles subsequent
to the 1999 study by Dougherty et al. only one study [56] was
echoed by three newspaper articles (Fig. 3). These newspaper
articles stated that DAT density was lower than normal in ADHD
patients but did not mention that this subsequent study refuted the
initial claim. The 1996 epidemiologic study published by Safer et
al. [26] was questioned by LeFever et al. [76] and this subsequent
study was echoed by 9 newspaper articles. All nine discussed
whether ADHD was overdiagnosed, but did not discuss the initial
data, i.e. the amplitude of the increase in the prevalence of MPH
treatment between 1990 and 1995 [26]. The 1994 study by
Wolraich et al. [22] investigating the effect of sugar on child
behavior was not followed by subsequent research, but it was
preceded by three studies in the early 1990s. Two of these three
studies [72,74] were echoed by four and one newspapers,
respectively. Because all four scientific studies concluded that
sugar ingestion does not significantly affect child behavior, all
newspaper articles reporting on them put forward the same
conclusion.
The conclusion of the 1999 MTA study [24] was attenuated by
three subsequent studies, of which two [89,90] were echoed by two
and one newspaper articles, respectively. This latter article was the
only newspaper article mentioning that a ‘‘top 10’’ finding has
been attenuated by the corresponding subsequent study. Indeed,
in the Washington Post (July 31, 2007) the journalist wrote: ‘‘The
study [by Jensen and coworkers] is a follow-up to a landmark
NIMH study published in 1999. In the earlier phase of the study,
nearly 600 children ages 7 to 9 with ADHD were randomly
assigned to one of four treatments for 14 months. Those whose
medication was managed by an ADHD specialist and those whose
treatment involved both drugs and behavioral therapy did far
better than those treated by a family physician or with behavior
therapy alone. But at the three-year mark, kids from all four
groups showed the same amount of improvement.’’

Among all available studies, the ‘‘top 10’’ publication reported the
largest protective effect of pharmacotherapy (Fig. 4). However, the
same group concluded in 2008: ‘‘the findings revealed no evidence
that stimulant treatment increases or decreases the risk for
subsequent SUD in children and adolescents with ADHD when
they reach young adulthood’’ [13].
Given public concerns regarding psychostimulants and lack of
evidence to guide long-term treatment of ADHD, the National
Institute of Mental Health sponsored in 1992 a randomized
clinical trial, the Multimodal Treatment Study of Children with
ADHD (MTA) [24]. A group of 579 children with ADHD were
randomly assigned for 14 months to medication management,
intensive behavioral therapy, the two combined treatments, or
standard community care. ‘‘For most ADHD symptoms children
in the medication management and combined treatment showed
greater improvement than those given behavioral treatment and
community care’’ [24]. Because MTA is the only study in which
large groups of children were randomly assigned to different
treatments [87], it should be considered as an initial study. Its
main conclusion has been confirmed by a smaller study [88].
However, the children enrolled in the MTA study were reassessed
10 [89] and 22 [90] months after the end of the initial study. This
follow-up showed a progressive and complete loss of superiority of
the medication strategy despite maintenance of psychostimulant
treatment [91].

Summary of the scientific follow-up of each ‘‘top 10’’
publication
References of all studies related to each ‘‘top 10’’ publication are
given in Table 2. Among these ‘‘top 10’’ publications, three were
refuted either by the same group [17,21] or by other researchers
[20]. The main conclusion in four was strongly attenuated by
subsequent studies [18,23–25]. One was neither confirmed nor
refuted, but its main conclusion appears very unlikely [19]. The
PLOS ONE | www.plosone.org
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Hauser

Wolraich

Lahoste

1994

1996

6

[33], [34],
[37], [38],
[41], [42],
[45]

[89], [90], [91]

[60], [61], [62]

[48], [49], [50], [51],
[52], [53], [54], [55],
[56], [57], [58]

[82], [83], [84], [86],
[14], [13]

No ref

[75], [76]

[32],
[36],
[40],
[44],

[88]

[85]

No ref

[77], [78], [80], [79]

[72], [73], [74]

supporting Ref
0

0

4.261.8

3

0

3

8.167.4

4.661.5

11

5.563.0

0

9

5

0

4.864.3

13.2619

Meta-analyses

[87]

[63], [64]

[59]

[81]

[46], [47]

[71]

Echoed (total)
#
Ref

5,860

4.562.1

7.765.9

IF, mean ±SD

IF: journal impact factor; echoed.
#
: number of newspaper articles echoing the corresponding studies; Ref: reference number in italic.
doi:10.1371/journal.pone.0044275.t002

MTA group

Dougherty

1999

1999

Biederman

1999

Gainetdinov

Vaidya

1998

1999

Safer

1996

[31],
[35],
[39],
[43],

[65], [66], [67], [68],
[69], [70]

[27], [28], [29], [30]

Zametkin

1990

1993

Year

refuting or
attenuating Ref

Related studies

1st author

‘‘Top 10

Table 2. ‘‘Top 10’’ publications and their related scientific studies.

7.6

9.3, 5.5

11.4

5.8

3.9, 3.8

27.8

IF

0

0

0

10

0

16

Echoed #

Attenuated

Attenuated

Refuted

Attenuated

Confirmation unlikely

Mostly confirmed

Attenuated

Confirmed

Refuted

Refuted

Scientific follow-up
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Figure 3. Association between ADHD and the dopamine
transporter level in initial and subsequent studies. Dougherty
and coworkers (1999) used brain imaging to show that the dopamine
transporter was more abundant (+70%) in the striatum of ADHD adults
than in control subjects. Subsequent studies did not confirm this
observation (data from a meta-analysis [59]). The effect calculated by
this meta-analysis is indicated by a diamond. Only one subsequent
study (filled circle) was echoed in newspapers (number of articles in
parentheses). Empty symbols indicated that the corresponding
scientific article has not been echoed by newspapers.
doi:10.1371/journal.pone.0044275.g003

Figure 4. Impact of ADHD pharmacotherapy on later substance
use disorder (SUD). According to the ‘‘top 10’’ study published by
Biederman et al. in 1999, ADHD children treated with psychostimulants
are at a 4-fold reduced risk of later SUD at adolescence. This study and
two studies published in 1998 and 2003 were taken into account in a
meta-analysis (corresponding OR indicated by a diamond). Circles
indicate pharmacotherapy outcome for SUD at adolescence and
squares at adulthood. Scientific studies echoed by newspapers are
indicated by filled symbols (number of articles in parentheses). Empty
symbols indicate that the corresponding scientific article has not been
echoed by newspapers.
doi:10.1371/journal.pone.0044275.g004

The only ‘‘top 10’’ publication that gave rise to a significant
public controversy is that by Biederman et al. [23]. Among the
seven scientific publications related to this 1999 study about the
effect of MPH treatment of ADHD children on later SUD risk,
three were echoed by newspapers (Fig. 4). When the study by
Lambert and Hartsough [82] was published in 1998, three
newspaper articles soon echoed its main conclusion: ‘‘Children on
Ritalin are three times more likely to develop a taste for cocaine’’
(New York Post, December 8, 1998). In 1999, 13 newspaper articles
again cited Lambert’s study when they echoed Biederman’s study.
Six of them supported the view that Biederman’s study refuted
Lambert’s study whereas the seven others gave a neutral report of
both studies. Regarding the six scientific studies subsequent to
1999 Biederman’ study, two [83,85] were echoed by five and three
newspaper articles, respectively. All these eight press articles put
forward this type of statement: ‘‘Children who take stimulants to
treat ADHD are at no greater risk for using illegal drugs when they
are teenagers or adults than children who are not treated with such
drugs’’ (New York Daily News, January 6, 2003). Moreover, the three
press articles reporting on the study by Wilens et al. (2008) added
that stimulant treatment may have a protective effect.

not echoed (6.461.0 mean 6 SEM), the difference is highly
significant (unpaired t test: p,0.0001).
When we compare the media coverage of our ‘‘top 10’’
publications to that of the 67 related scientific articles, including
meta-analyses (Tables 1 and 2), the difference is huge and seems
related to the fact that the averaged impact factor of the related
publications is almost always lower than that of the corresponding
‘‘top 10’’ article. More precisely, we observe a strong positive
relationship between the magnitude of the newspaper coverage
and the impact factor of the corresponding scientific publication
(Fig. 6). There are two notable exceptions however. The increase
in the prevalence of MPH treatment reported in 1996 by Safer et
al. [26] was less alarming than that published in 1995 by Swanson
et al. [75]. This previous study was published in a high impact
factor journal (51.4), but was not echoed by newspapers, whereas
Safer’s study received wide media coverage although it appeared
in a journal with a much lower impact factor (5.8). Likewise,
Biederman et al. reported in 1999 a large protective effect of
pharmacotherapy on later SUD risk [23], but reported a null effect
in 2008 [13]. Although the latter publication appeared in a journal
with a higher impact factor (11.4 compared to 5.8), only the
former was echoed by newspapers.

Media coverage and journal impact factor
In our initial search of scientific publications related to ADHD
published in the 1990s and echoed by newspapers we found 47
studies. On average, the impact factor of the journals that
published the ‘‘top 10’’ studies (26.666.0 mean 6 SEM) is larger
than for the 37 remaining publications (15.062.3 mean 6 SEM)
and this difference is statistically significant (unpaired t test:
p = 0.038). However, we observe no significant relationship
between the impact factor of the corresponding journal and the
number of newspaper articles reporting on these 47 publications
(Fig. 5). When we pool the 47 initial publications with their 67
related publications we obtain two doubloons and 112 distinct
publications. When we compare the average impact factor of the
56 scientific publications that were echoed by newspapers
(17.162.1 mean 6 SEM) to that of the 56 publications that were
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Media coverage and university ranking
When considering the 47 scientific publications of our initial
search that newspapers echoed during the 1990s, we observe a
positive relationship between the prestige of the university in
which the study was performed and the number of newspaper
articles reporting on it (Fig. 5). This relationship is much more
significant (p = 0.0017) than that with the journal impact factor.
Regarding the ‘‘top 10’’ publications and their 67 related studies,
we also observe a positive relationship between the prestige of the
university in which the study was performed and the number of
newspaper articles reporting on it (Fig. 6).
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Figure 5. Newspaper coverage of the 47 scientific studies related to ADHD between 1990 and 1999. The number of newspaper articles
reporting on each scientific study is expressed as a function of the impact factor of the scientific journal publishing the scientific study (left), or the
ranking of the university in which the study was performed (right). The ranking for medicine and pharmacy was that given by ARWU in 2010
(‘‘Shanghai Ranking’’). The relationship with the impact factor is not statistically significant (R2 = 0.06 ANOVA: f = 3.0 p = 0.09) whereas that with the
university ranking is significant (R2 = 0.20 ANOVA: f = 11.2 p = 0.0017). The ‘‘top10’’ articles are indicated by filled circles.
doi:10.1371/journal.pone.0044275.g005

precisely, scientific studies related to eight ‘‘top 10’’ articles
received only marginal media coverage whereas the 12 studies
related to Wolraich et al. (1994) and to Biederman et al. (1999)
received a total media coverage similar in size to both of their
corresponding ‘‘top 10’’ publications. Therefore, in the case of
ADHD, our observations are consistent with our prediction based
on Ioannidis’ studies: subsequent scientific articles that refute or
attenuate initial studies are much less echoed by newspapers than
initial studies. Moreover, only one of these few newspaper articles
mentioned that the subsequent study it echoed actually attenuated
the corresponding ‘‘top 10’’ claim. In other words, at least in the
case of ADHD, we observed an almost complete amnesia in the
newspaper coverage of biomedical findings.
We hypothesized that this much lower coverage of subsequent
studies was related to the lower impact factor of the journals that
published them. Our observations are strongly consistent with this
prediction when we compared the coverage of ‘‘top 10’’
publications with that of their 67 related studies. However,
regarding the newspaper coverage of the 47 scientific publications
of our initial search, its amplitude is not significantly correlated
with the impact factor, but rather with the ranking of the
university where the study was performed. This suggests that the
publication of a scientific study in a high impact factor journal is a

Discussion
Comments
Among ‘‘top 10’’ publications only two studies passed the test of
the years, three studies were fully refuted, four were substantially
attenuated by subsequent articles and one was not confirmed or
refuted though its main conclusion appears unlikely. These
seemingly astonishing proportions are nonetheless quite consistent
with the devaluation trend of biomedical findings described by
Ioannidis and coworkers [6–8]. Previous studies suggest that this
devaluation trend stems from the fact that initial observations
showing a positive effect are much more often published than
those reporting no effect [6,7,9]. As a consequence, initial
observations are often refuted or attenuated by subsequent studies
[6–8]. Our findings support this interpretation. Indeed, among the
seven ‘‘top 10’’ publications that were refuted or attenuated by
subsequent
studies,
six
reported
initial
observations
[17,18,20,21,24,25]. In contrast, both ‘‘top 10’’ publications that
were subsequently confirmed did not report initial observations
[22,26].
As a whole, ‘‘top 10’’ publications received a much larger press
coverage (223 newspaper articles) than the 67 related scientific
studies, including meta-analyses (57 newspaper articles). More

Figure 6. Newspaper coverage of ‘‘top 10’’ publications and of their 67 related scientific studies. The number of newspaper articles
reporting on each scientific study is expressed as a function of either the impact factor of the scientific journal publishing the scientific study (left), or
the ranking of the university in which the study was performed (right). The relationship with the impact factor (R2 = 0.33 ANOVA: f = 36.8 p,0.0001)
and with the university ranking (R2 = 0.10 ANOVA: f = 8.4 p = 0.005) are statistically significant. The ‘‘top10’’ publications are indicated by filled circles.
doi:10.1371/journal.pone.0044275.g006
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To quantify media coverage, we considered only newspaper
articles published from one day preceding to nine days following
the publication of each scientific study. Indeed, when newspaper
articles appeared much later than the scientific publication, it was
often impossible to identify it with certainty. Consequently, we did
not examine the long-term impact of scientific publications in the
lay press. However, in relative terms, it is likely that the scientific
publications with the strongest long-term impact also received the
widest newspaper coverage shortly following their publication.
Here we only investigated the coverage of scientific findings by
newspapers. Although generalization of our observations to other
media, especially television, is still hypothetical, it is unlikely that
television provides more contextualized and in-depth reports than
newspapers. Indeed, the televised reporting of discoveries related
to genetic diseases appears less accurate than in newspapers [93].

prerequisite, but does not guarantee a strong media coverage. The
prestige of the university seems to exert an additional influence.
Indeed, famous universities have powerful press offices that may
help their researchers obtain press coverage [92].
Scientific knowledge always matures from initial and uncertain
findings to validated findings. This process often results from the
debate of conflicting opinions in the scientific literature. Accordingly, apart from Wolraich’s study, our ‘‘top 10’’ publications were
involved in scientific debates. However, their press coverage never
reflected these debates, apart from a notable, but restricted,
exception: the conflicting observations reported by Lambert and
Hartsough (1998) and by Biederman et al. (1999). Therefore, as a
whole these newspaper articles put forward scientific findings to
defend the view that ADHD is a neurological disease mainly
caused by genetic factors and that psychostimulant treatments are
safe and effective. This is not to say that all press articles published
in the 1990s about ADHD echoed the same line. We found several
press articles defending the view that ADHD is mainly a social
construct, or a disorder caused by environmental factors, and
questioning the safety and effectiveness of psychostimulant
medication. However, these press articles usually cited medical
opinions but, apart from comments on Lambert and Hartsough’s
study, were not based on scientific observations published in peerreviewed journals.
The fact that almost all newspaper articles included in the
present study promote a medicalized view of ADHD results largely
from our process of selecting articles reporting on biomedical
findings. However, in the course of the present study we observed
three notable exceptions suggesting a reporting bias favoring a
medical conception of ADHD and its treatment. Both ‘‘top 10’’
publications in Pediatrics [23,26] offered conclusions that were
attenuated by two related studies, but these studies received no
media coverage although they were published in more prestigious
journals. The third exception is an example of refutation: six
newspaper articles reporting in 1999 on Biederman’s study about
the protective effect of pharmacotherapy towards SUD [23]
pointed out that this ‘‘top 10’’ study refuted a previous publication
on the same topic [82]. Although these reporting exceptions may
reflect a biased conception of ADHD, our observations cannot tell
whether scientists, journalists, or both, were responsible for it.

Conclusions
During the 1990s, press coverage of scientific studies about the
biology and etiology of ADHD contributed ‘‘to much wider
acceptance of the disorder as having neurological and genetic,
rather than environmental origins’’ [16]. Newspaper articles
reporting on our ‘‘top 10’’ publications repeatedly claimed that
these findings might soon result in improved pharmacological
treatments and in commercially available biomarkers to confirm
the ADHD diagnosis. None of these promises have yet been
fulfilled. Moreover, general agreement now exists among scientists
that environmental risk factors play a central role in ADHD
etiology [94–96]. Because newspapers failed to inform the lay
public that most initial scientific claims were later refuted or
strongly attenuated, they did not reflect the evolution of scientific
knowledge. In turn, because scientific findings echoed by
newspapers are more often cited in the scientific literature [97],
this biased media coverage probably favors the visibility of initial
findings. Therefore, not only the lay public but also a substantial
proportion of interested professionals, scientists and clinicians
might be influenced by this inaccurate media coverage. This might
have detrimental consequences on the management and prevention of ADHD [98].
We showed here, using the example of ADHD, that press
coverage of health issues, by strongly favoring initial studies,
ignores the publication bias resulting from the devaluation trends
of initial findings. If further investigations of other health issues
confirm our observations and reinforce our interpretations, it
might be timely for scientists, journal editors and university media
writers to define and respect ethical rules regarding health science
communication. For example, press releases reporting on an initial
study should include a warning statement pointing out that these
findings must be confirmed by subsequent independent investigations. Indeed, the quality of press releases positively influences the
quality of associated newspaper stories [99]. The time would be
also right to warn journalists about this major publication bias
inherent to the scientific process.

Limitations
Because we only focused on ADHD, generalization of our
observations to other biomedical domains remains hypothetical.
However, the hypothesis that grounded our study originated from
the seminal studies by Ioannidis and coworkers [6–8]. Because
these studies covered a wide range of biomedical topics, our main
finding might also hold true regarding most medical conditions:
media reporting strongly favors initial studies although most of
them are refuted or attenuated by subsequent studies.
We investigated scientific studies and their newspaper coverage
published during the 1990s. The 12-year delay between this
selected decade and the present study was required to test whether
subsequent studies consistently confirmed ‘‘top 10’’ studies. We do
not know whether journalists pay more attention to replication of
initial findings today than during the 1990s.
We focused on the ten publications related to ADHD that
received the widest press coverage from 1990 to 1999. We did not
investigate the scientific follow-up of all 47 publications that were
echoed at least once. Although this selection might affect our
conclusions, it is justified by the fact that the media coverage of the
‘‘top 10’’ publications (223 articles) was nearly seven times larger
than that of the 37 others (124 articles).
PLOS ONE | www.plosone.org
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